Posts Tagged ‘Multiple Sclerosis’
Fred A. Baughman, Jr. MD
A neurologist in private practice for 35 years, he differentiates real diseases — epilepsy, brain tumor, multiple sclerosis, etc. — from “no disease” diagnoses — emotional, psychological, psychiatric. . . .
Read MoreObama Administration Propsal: Anthrax Vaccine Experiment on Children
Whose children are to be selected for morally and legally impermissible medical experiments?
Read MoreArt Caplan Challenged With Evidence of HPV Vaccine Harm
As of June 2011 there have been 68 deaths related to the HPV Gardasil vaccine were reported to VAERS.
Read MoreAHRP Leads Opposition to Proposed Anthrax Vaccine Trial in Children
The Alliance for Human Research Protection speaks out against a US government-proposed anthrax vaccine experiment on children. Such an experiment would sacrifice children’s welfare, much as canaries sent into the coal mines were sacrificed.
Read MoreAdult Stem Cells Repair Brain Damaged Cess Without Transplant
Before 2007, the research community had dogmatically insisted that only embryonic stem cell research would be medically useful, and that adult stem cell research was a waste of resources and effort. The contentious debate was framed as between “enlightened” scientists and religious fundamentalists. Like many dogmatic theoretical constructs–this one proved to be false. The Institute…
Read MoreRE: Stimulus Funding to Compare Treatments_Scientific American
AHRP Quoted in Scientific American
Read MoreAnother deadly drug recalled – FDA asks Congress for Power to Dictate Warnings
Another deadly drug recalled – FDA asks Congress for Power to Dictate Warnings Tue, 1 Mar 2005 Public pressure has intensified as FDA’s failure to protect the public from unsafe – even lethal drugs. That failure included the failure to at least warn physicians and the public about severe adverse drug effects. The Associated Press…
Read MoreCharitable Choice: Research Grants–Juvenile Diabetes Research Foundation – National Journal
Charitable Choice: Research Grants–Juvenile Diabetes Research Foundation – National Journal Tue, 8 Mar 2005 The Washington Post reports that conservatives have crafted a “bioethics agenda” on cloning and stem cell research. Such an agendaq determines what research the government will and will not fund. http://www.washingtonpost.com/wp-dyn/articles/A15569-2005Mar7.html Below is an excerpt of a fascinating article in the…
Read MoreAnthrax Vaccine Not Safe and Effective – Emergency Medicine News
July 18, 2002 Anthrax Vaccine Not Safe and Effective – Emergency Medicine News FYI In her letter in the July issue of Emergency Medicine News (below) Dr. Meryl Nass cites a body of evidence linking the anthrax vaccine with systemic adverse medical reactions, and 100,000 to possibly 200,000 veterans who suffered adverse reactions. Dr. Nass…
Read MoreMarketing Diseas – NYT /APA invites Soprano-Actress Psychiatrist– Pfizer Spokeswoman to speak at conference
Marketing Diseas – NYT /APA invites Soprano-Actress Psychiatrist– Pfizer Spokeswoman to speak at conference Fri, 13 May 2005 The New York times reported how drug companies invent and market a disease in order to ensure a market for newly developed drugs. Under the influence of the pharmaceutical industry, illness does not guide the use of…
Read MoreTIME inquiry finds top officials at vital gov agencies lack credentials for the job
TIME inquiry finds top officials at vital gov agencies lack credentials for the job Date: Wed, 28 Sep 2005 The New York Times reports today that the mystery of Lester Crawford’s abrupt resignation as head of the FDA “fueled speculation that he had investments in companies regulated by the FDA." The Times reports that Crawford’s…
Read MoreFDA Official Admits ‘Lapses’ on Vioxx – FDA Didn’t Heed Warnings on Dangers of MS Drug
FDA Official Admits ‘Lapses’ on Vioxx – FDA Didn’t Heed Warnings on Dangers of MS Drug Wed, 2 Mar 2005 As the Senate committee on Health, Education, Labor and Pensions prepares for the second day hearing about FDA’s performance, one hopes that the committee will follow up Tuesday’s hearing with some tough questions about FDA’s…
Read More